Literature DB >> 11248655

The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-alpha, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells.

Y Fujikawa1, A Sabokbar, S D Neale, I Itonaga, T Torisu, N A Athanasou.   

Abstract

Macrophage-colony stimulating factor (M-CSF) is an essential requirement for human osteoclast formation, but its effect on the proliferation and differentiation of circulating osteoclast precursor cells is unknown. Other growth factors and cytokines are also known to support/stimulate osteoclast formation from mouse marrow precursors, but it is not certain whether these factors similarly influence human osteoclast formation. In this study, human monocytes were cocultured with osteoblast-like UMR-106 cells on coverslips and dentine slices for up to 21 days in the presence of 1,25 dihydroxyvitamin D(3) (10(-7) mol/L), dexamethasone (10(-8) mol/L), and various concentrations of either M-CSF or other humoral factors (interleukin [IL]-1beta, IL-3, IL-6, and IL-11; tumor necrosis factor-alpha [TNF-alpha]; and granulocyte macrophage [GM]-CSF). The effect on osteoclast formation was assessed by tartrate-resistant acid phosphatase (TRAP) and vitronectin receptor staining and lacunar bone resorption. The results of time-course and proliferation studies showed that M-CSF stimulated both the proliferative and differentiation stages of human osteoclast formation from circulating osteoclast precursors in a dose-dependent manner. A high concentration of M-CSF (100 ng/mL) did not inhibit osteoclast formation. IL-3 and GM-CSF were also capable of stimulating human osteoclast formation, although these growth factors were much less potent than M-CSF. IL-3- and GM-CSF-stimulated osteoclast formation was inhibited by an antibody specific for human M-CSF. Osteoclast formation and lacunar resorption was not seen when either TNF-alpha, IL-1beta, IL-6 (+ soluble IL-6 receptor), or IL-11 was substituted for M-CSF during coculture. These results confirm that M-CSF is essential for human osteoclast formation from circulating mononuclear precursors, and also shows that IL-3 and GM-CSF may support osteoclast differentiation via the stimulation of M-CSF production by human monocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11248655     DOI: 10.1016/s8756-3282(00)00453-1

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  19 in total

1.  Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions.

Authors:  Feng-Chun Yang; Shi Chen; Alexander G Robling; Xijie Yu; Todd D Nebesio; Jincheng Yan; Trent Morgan; Xiaohong Li; Jin Yuan; Janet Hock; David A Ingram; D Wade Clapp
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

2.  TRE17/ubiquitin-specific protease 6 (USP6) oncogene translocated in aneurysmal bone cyst blocks osteoblastic maturation via an autocrine mechanism involving bone morphogenetic protein dysregulation.

Authors:  Alan W Lau; Lashon M Pringle; Laura Quick; Daisy N Riquelme; Ying Ye; Andre M Oliveira; Margaret M Chou
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

3.  Multiple increased osteoclast functions in individuals with neurofibromatosis type 1.

Authors:  David A Stevenson; Jincheng Yan; Yongzheng He; Huijie Li; Yaling Liu; Qi Zhang; Yongmin Jing; Zhiping Guo; Wei Zhang; Dalong Yang; Xiaohua Wu; Heather Hanson; Xiaohong Li; Karl Staser; David H Viskochil; John C Carey; Shi Chen; Lucy Miller; Kent Roberson; Laurie Moyer-Mileur; Menggang Yu; Elisabeth L Schwarz; Marzia Pasquali; Feng-Chun Yang
Journal:  Am J Med Genet A       Date:  2011-04-04       Impact factor: 2.802

4.  Developmental potential of isolated blastomeres from early mouse embryos in the presence and absence of LIF and GM-CSF.

Authors:  Behnaz Sheikholslami; Mojdeh Salehnia; Mojtaba Rezazadeh Valojerdi; Mehdi Ramezanzadeh
Journal:  J Assist Reprod Genet       Date:  2008-01-18       Impact factor: 3.412

5.  Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.

Authors:  S-M Dai; K Nishioka; K Yudoh
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

6.  Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts.

Authors:  D O' Gradaigh; D Ireland; S Bord; J E Compston
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

7.  IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis.

Authors:  Wei Zhang; Xiao-Liang Cong; Yang-Hua Qin; Zheng-Wen He; Dong-Yi He; Sheng-Ming Dai
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

Review 8.  Cellular targets of interleukin-18 in rheumatoid arthritis.

Authors:  Sheng-Ming Dai; Zheng-Zheng Shan; Huji Xu; Kusuki Nishioka
Journal:  Ann Rheum Dis       Date:  2007-05-14       Impact factor: 19.103

9.  Blockage of hemichannels alters gene expression in osteocytes in a high magneto-gravitational environment.

Authors:  Huiyun Xu; Dandan Ning; Dezhi Zhao; Yunhe Chen; Dongdong Zhao; Sumin Gu; Jean Xin Jiang; Peng Shang
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01

10.  Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.

Authors:  Hae-Rim Kim; Kyoung-Woon Kim; Hong Geun Jung; Kwang-Sup Yoon; Hye-Jwa Oh; Mi-La Cho; Sang-Heon Lee
Journal:  Arthritis Res Ther       Date:  2011-03-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.